https://www.selleckchem.com/pr....oducts/epacadostat-i
Patients in whom both the donor and recipient had positive CMV serostatuses were less likely to have drug-resistant mutations (Fisher's exact test, p 0.05). Newly and previously detected CMV mutations in UL97 and UL54 may be associated with the development of drug-resistant CMV infection. The detection of these mutations may provide guidance for the management of post-transplant CMV infections. Newly and previously detected CMV mutations in UL97 and UL54 may be associated with the development of drug-resistant CMV in